Skip to main content
Equibles

PBMWW · Psyence Biomedical Ltd.

Track PBMWW — free

Use PBMWW with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PBMWW.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.02 At close · Oct 23
Rebalance outlook locked
Market Cap
$15.89M
Shares
3.81M
Volume · Oct 23 4000 Avg daily vol (3M) 34.82K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.02 Open$0.02 Day$0.02–0.02 Available close range$0.02–0.04 Avg vol 30d35K DataJul 2026–Oct 2026

The closing range uses available history since Jul 23, 2026; less than a full year is stored.

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+33% holders QoQ · +8 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
28 holders — mid 2-yr range
Price context
position in its available closing range
Range low $0 Now $0 · 0% Range high $0
vs 50-day avg -39%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PBMWW
Psyence Biomedical Ltd.
this stock
$15.89M — — — —
VRTX
Vertex Pharmaceuticals Inc
 $133.55B +15.6% +46.2% 30.7 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
 $82.88B +4.3% +20.8% 19.9 2.1%
MRNA
Moderna, Inc.
 $79.89B +578.5% +4.3% — 7.7%
CSLLY
Csl Ltd
 $66.42B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
28
% held
148.5%
Net QoQ
+115.5K sh
Top holder
Harraden Circle Investmen…
Held Float
View
Held by Funds
Fund positions
1
View
Short & Settlement
Fails to Deliver
FTD shares
1.0K
Value
$6.4K
As of
Sep 24, 2026
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 21, 2026
This year
24

Psyence Biomedical Ltd. completed an additional US$2,599,896 investment in Psyence Labs Ltd. after ibogaine regulatory-readiness and U.S. cGMP manufacturing milestones were met, increasing its ownership from approximately 41.13% to approximately 43.37%.

View
Exempt Offerings
Offering
$2.0M
Filed
Jan 7, 2025
View

Performance

5D 20D 120D MTD YTD
PBMWW +0.0% -47.2% — -28.1% —
SPY -0.4% -1.5% +5.8% -0.4% +11.5%
vs SPY +0.4% -45.7% — -27.8% —
Key facts CIK 1985062 CUSIP 74449F407 Visit website Investor relations